United Therapeutics Corporation Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase
United Therapeutics Corporation (UTHR) had Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase of 4.00% as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease · last filed 2026-02-25
- 2025-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 4.00%.
- 2024-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 4.00%.
- 2023-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 4.00%.
- 2022-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 4.00%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase |
|---|---|
| 2025-12-31 | 4.00% 10-K · filed 2026-02-25 |
| 2024-12-31 | 4.00% 10-K · filed 2026-02-25 |
| 2023-12-31 | 4.00% 10-K · filed 2025-02-26 |
| 2022-12-31 | 4.00% 10-K · filed 2024-02-21 |
| 2021-12-31 | 4.00% 10-K · filed 2023-02-22 |
| 2020-12-31 | 4.00% 10-K · filed 2022-02-24 |
| 2019-12-31 | 4.00% 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |